These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 22507372

  • 21. Treatment of isoniazid-resistant pulmonary tuberculosis.
    Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Lim SY, Lim SY, Koh WJ.
    BMC Infect Dis; 2008 Jan 23; 8():6. PubMed ID: 18211720
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Outcomes of pulmonary tuberculosis in patients with discordant phenotypic isoniazid resistance testing.
    Kim S, Lee H, Park HY, Jeon K, Huh HJ, Lee NY, Jeong BH.
    Respir Med; 2017 Dec 23; 133():6-11. PubMed ID: 29173450
    [Abstract] [Full Text] [Related]

  • 27. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
    Hamusse SD, Teshome D, Hussen MS, Demissie M, Lindtjørn B.
    BMC Public Health; 2016 Jul 18; 16():593. PubMed ID: 27430266
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis.
    Cattamanchi A, Dantes RB, Metcalfe JZ, Jarlsberg LG, Grinsdale J, Kawamura LM, Osmond D, Hopewell PC, Nahid P.
    Clin Infect Dis; 2009 Jan 15; 48(2):179-85. PubMed ID: 19086909
    [Abstract] [Full Text] [Related]

  • 30. Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005-2015.
    Pradipta IS, Van't Boveneind-Vrubleuskaya N, Akkerman OW, Alffenaar JC, Hak E.
    Antimicrob Resist Infect Control; 2019 Jan 15; 8():115. PubMed ID: 31338162
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar 15; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 34. Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
    Gao J, Ma Y, Du J, Zhu G, Tan S, Fu Y, Ma L, Zhang L, Liu F, Hu D, Zhang Y, Li X, Li L, Li Q.
    BMC Pulm Med; 2016 Feb 04; 16():26. PubMed ID: 26846562
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Six- vs. eight-month anti-tuberculosis regimen for pulmonary tuberculosis under programme conditions.
    Ukwaja KN, Oshi SN, Alobu I, Oshi DC.
    Int J Tuberc Lung Dis; 2015 Mar 04; 19(3):295-301, i-vii. PubMed ID: 25686137
    [Abstract] [Full Text] [Related]

  • 37. Drug resistance of Mycobacterium tuberculosis isolated from treated patients in Pakistan.
    Aziz A, Siddiqi SH, Aziz K, Ishaq M.
    Tubercle; 1989 Mar 04; 70(1):45-51. PubMed ID: 2476880
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?
    Trentalange A, Borgogno E, Motta I, Antonucci M, Pirriatore V, Costa C, Rossi G, Barco A, De Nicolò A, Piccioni P, D'Avolio A, Bonora S, Di Perri G, Calcagno A.
    Int J Antimicrob Agents; 2021 Mar 04; 57(3):106297. PubMed ID: 33539932
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.